Información del producto
2-(Pyridin-3-yl)propanoic acid is a quinoline derivative that has been shown to be safe and effective in clinical trials. It is being tested for the treatment of type 2 diabetes, obesity, and metabolic syndrome. The oral administration of this drug inhibits the activity of dipeptidyl peptidase-4 (DPP-4), which is an enzyme involved in the degradation of insulin. This inhibition leads to increased levels of insulin in the blood and improved glucose tolerance. 2-(Pyridin-3-yl)propanoic acid interacts with other drugs through competitive inhibition at their binding sites on enzymes. Optimization experiments have shown that it can interact with pyridine compounds, which are found in many drugs including acetaminophen and caffeine.
Propiedades químicas
Consulta técnica sobre: 3D-QDA00562 2-(Pyridin-3-yl)propanoic acid
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
